InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Conway Charles, Directeur Scientifique. Director active across 1 company, notably Biohaven Pharmaceutical Holding Co Ltd.. In total, 3 reports have been logged. History available since 23 November 2021. The latest transaction was disclosed on 3 October 2022 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Charles Conway is the Chief Scientific Officer at Biohaven Pharmaceutical Holding Co Ltd. In this role, he oversees the company's research and development initiatives, contributing to innovation and scientific advancement. His expertise is essential for Biohaven.